Literature DB >> 2493774

Anticardiolipin versus lupus anticoagulant tests: no final judgment.

E N Harris.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2493774      PMCID： PMC1003685          DOI： 10.1136/ard.48.1.84

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  4 in total

1.  Thrombosis, abortion, cerebral disease, and the lupus anticoagulant.

Authors:  G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-15

2.  Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test.

Authors:  E N Harris; J K Chan; R A Asherson; V R Aber; A E Gharavi; G R Hughes
Journal:  Arch Intern Med       Date:  1986-11

3.  Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986.

Authors:  E N Harris; A E Gharavi; S P Patel; G R Hughes
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

4.  Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients.

Authors:  R H Derksen; P Hasselaar; L Blokzijl; F H Gmelig Meyling; P G De Groot
Journal:  Ann Rheum Dis       Date:  1988-05       Impact factor: 19.103
  4 in total
  1 in total

1.  Neurological disease associated with anticardiolipin antibodies in patients without systemic lupus erythematosus: clinical and immunological features.

Authors:  A M Chancellor; R E Cull; D C Kilpatrick; C P Warlow
Journal:  J Neurol       Date:  1991-10       Impact factor: 4.849
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.